Skip Navigation


European Heart Journal Advance Access originally published online on May 22, 2006
European Heart Journal 2006 27(15):1868-1875; doi:10.1093/eurheartj/ehl013
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Supplementary colour figures
Right arrow All Versions of this Article:
27/15/1868    most recent
ehl013v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Neilan, T. G.
Right arrow Articles by Scherrer-Crosbie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neilan, T. G.
Right arrow Articles by Scherrer-Crosbie, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Tissue Doppler imaging predicts left ventricular dysfunction and mortality in a murine model of cardiac injury

Tomas G. Neilan1,2, Davinder S. Jassal1, Teresa M. Perez-Sanz1, Michael J. Raher2, Aruna D. Pradhan4, Emmanuel S. Buys2, Fumito Ichinose2, David B. Bayne2, Elkan F. Halpern3, Arthur E. Weyman1, Geneviéve Derumeaux5, Kenneth D. Bloch2, Michael H. Picard1 and Marielle Scherrer-Crosbie1,2,*

1 Cardiac Ultrasound Laboratory
2 Cardiovascular Research Center, Cardiology Division of the Department of Medicine, Harvard Medical School USA
3 Institute for Technology Assessment, Massachusetts General Hospital USA
4 Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, USA
5 Department of Cardiology, Hospital Louis Pradel, Lyon, France

Received 17 October 2005; revised 7 April 2006; accepted 13 April 2006; online publish-ahead-of-print 22 May 2006.

* Corresponding author. Tel: +1 617 7267686; fax: +1 617 7268383. E-mail address: marielle{at}crosbie.com

See page 1771 for the editorial comment on this article (doi:10.1093/eurheartj/ehl144)

Aims Currently available non-invasive imaging methods frequently fail to detect alterations in left ventricular (LV) function despite histological evidence of injury. Tissue Doppler imaging (TDI) can detect subtle LV dysfunction. The aim of this study was to investigate whether TDI indices can predict LV systolic dysfunction and mortality following exposure to doxorubicin (DOX) in mice.

Methods and results TDI-derived peak endocardial systolic velocity (VENDO) and strain rate (SR), as well as M-mode and two-dimensional indices of LV systolic function, were measured serially in mice after receiving DOX as a single dose (20 mg/kg). Haemodynamic measurements were obtained invasively before and at 1, 2, 4, and 5 days after the single DOX dose. Cardiac apoptosis was measured before and at 1 day after DOX. VENDO and SR decreased after 1 and 2 days, respectively, whereas changes in fractional shortening (FS) and LV ejection fraction (LVEF) were not detected before 5 days. The reduction in both VENDO and SR correlated with the decrease in dP/dtMAX, and the change in VENDO correlated with the early increase in cardiac cell apoptosis. In a subsequent experiment, DOX was administered at 4 mg/kg/week for 5 weeks, and LV function was followed serially for 16 weeks. In this chronic experiment, TDI indices decreased before FS and LVEF, correlated with late LV dysfunction, and predicted DOX-induced mortality.

Conclusion In a murine model of DOX-induced cardiac injury, TDI detects LV dysfunction prior to alterations in conventional echocardiographic indices and predicts mortality. This study suggests that TDI may be a reliable tool to detect early subtle changes in DOX-induced cardiac dysfunction.

Key Words: Echocardiography • Tissue Doppler imaging • Doxorubicin • Apoptosis • Heart failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Detection of subclinical LV dysfunction by tissue Doppler imaging
Frank Weidemann and Joerg M. Strotmann
EHJ 2006 27: 1771-1772. [Extract] [FREE Full Text]  



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Peng, Z. B. Popovic, N. Sopko, J. Drinko, Z. Zhang, J. D. Thomas, and M. S. Penn
Speckle tracking echocardiography in the assessment of mouse models of cardiac dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2009; 297(2): H811 - H820.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Mukhopadhyay, M. Rajesh, S. Batkai, Y. Kashiwaya, G. Hasko, L. Liaudet, C. Szabo, and P. Pacher
Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1466 - H1483.
[Abstract] [Full Text] [PDF]


Home page
Eur J EchocardiogrHome page
K. George, R. Shave, D. Oxborough, T. Cable, E. Dawson, N. Artis, D. Gaze, T. Hew-Butler, K. Sharwood, and T. Noakes
Left ventricular wall segment motion after ultra-endurance exercise in humans assessed by myocardial speckle tracking
Eur J Echocardiogr, March 1, 2009; 10(2): 238 - 243.
[Abstract] [Full Text] [PDF]


Home page
Circ Cardiovasc ImagingHome page
G. Derumeaux, F. Ichinose, M. J. Raher, J. G. Morgan, T. Coman, C. Lee, J. M. Cuesta, H. Thibault, K. D. Bloch, M. H. Picard, et al.
Myocardial Alterations in Senescent Mice and Effect of Exercise Training: A Strain Rate Imaging Study
Circ Cardiovasc Imaging, November 1, 2008; 1(3): 227 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. D. Huebner, D. S. Jassal, O. Halevy, M. Pines, and J. E. Anderson
Functional resolution of fibrosis in mdx mouse dystrophic heart and skeletal muscle by halofuginone
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1550 - H1561.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. Mukhopadhyay, S. Batkai, M. Rajesh, N. Czifra, J. Harvey-White, G. Hasko, Z. Zsengeller, N. P. Gerard, L. Liaudet, G. Kunos, et al.
Pharmacological Inhibition of CB1 Cannabinoid Receptor Protects Against Doxorubicin-Induced Cardiotoxicity
J. Am. Coll. Cardiol., August 7, 2007; 50(6): 528 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Thibault, L. Gomez, E. Donal, G. Pontier, M. Scherrer-Crosbie, M. Ovize, and G. Derumeaux
Acute myocardial infarction in mice: assessment of transmurality by strain rate imaging
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H496 - H502.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Ballo, A. Bocelli, and S. Mondillo
Adaptive and Maladaptive Cardiac Hypertrophy: What Is the Effective Role of Heat Shock Transcription Factor 1?
Circ. Res., February 16, 2007; 100(3): e45 - e46.
[Full Text] [PDF]


Home page
Eur Heart JHome page
T. G. Neilan and D. J. Fitzgerald
Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumor suppression: reply
Eur. Heart J., November 1, 2006; 27(21): 2611 - 2611.
[Full Text] [PDF]


Home page
Eur Heart JHome page
F. Weidemann and J. M. Strotmann
Detection of subclinical LV dysfunction by tissue Doppler imaging
Eur. Heart J., August 1, 2006; 27(15): 1771 - 1772.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.